Cambridge Investment Research Advisors, Inc. United Therapeutics Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 9,179 shares of UTHR stock, worth $2.73 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,179
Previous 6,968
31.73%
Holding current value
$2.73 Million
Previous $2.46 Million
15.09%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding UTHR
# of Institutions
734Shares Held
43.1MCall Options Held
125KPut Options Held
124K-
Black Rock Inc. New York, NY5.47MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.33 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$796 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$664 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$627 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...